You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: July 12, 2025

Details for Patent: 10,774,072


✉ Email this page to a colleague

« Back to Dashboard


Which drugs does patent 10,774,072 protect, and when does it expire?

Patent 10,774,072 protects OMLONTI and is included in one NDA.

This patent has eight patent family members in seven countries.

Summary for Patent: 10,774,072
Title:Crystal of N-substituted sulfonamide compound
Abstract:The present invention relates to a method for producing N-substituted sulfonamide compounds including a step of reacting a sulfonamide compound of general formula (1) with a halogenated organic compound of general formula (2) in the presence of cesium carbonate or potassium carbonate in an organic solvent to produce an N-substituted sulfonamide compound of general formula (3).
Inventor(s):Yasuhito Yamamoto, Masayoshi Oue, Yukinori Wada
Assignee:Ube Corp
Application Number:US16/556,978
Patent Claim Types:
see list of patent claims
Patent landscape, scope, and claims:

Understanding the Scope and Claims of United States Patent 10,774,072

Introduction

United States Patent 10,774,072, titled "Crystal of N-substituted sulfonamide compound," is a patent that delves into the production and characteristics of a specific class of chemical compounds. This analysis will explore the key aspects of this patent, including its claims, the process of producing the compounds, and the broader patent landscape.

Background of the Patent

The patent in question, US10774072B2, is focused on N-substituted sulfonamide compounds, which are important in various chemical and pharmaceutical applications. These compounds often serve as intermediates or final products in the synthesis of drugs and other chemical entities.

Claims of the Patent

The patent includes several claims that define the scope of the invention. Here are the main types of claims:

Independent Claims

These claims stand alone and define the broadest scope of the invention. For US10774072B2, the independent claims typically involve the method of producing the N-substituted sulfonamide compounds, including the specific steps and reactants involved.

Dependent Claims

Dependent claims build upon the independent claims and provide more specific details or limitations. These claims might include variations in the reaction conditions, specific substituents on the sulfonamide group, or additional steps in the synthesis process.

Composition of Matter Claims

These claims focus on the N-substituted sulfonamide compounds themselves, describing their structure, properties, and any unique characteristics that distinguish them from prior art.

Method of Producing N-substituted Sulfonamide Compounds

The patent outlines a method for producing these compounds, which generally involves the reaction of a sulfonamide compound with a suitable substituent. Here are the key steps:

Reactants and Conditions

  • The process starts with a sulfonamide compound, which is reacted with a substituent group under specific conditions.
  • The reaction may involve catalysts, solvents, and temperature control to ensure the desired product is formed.

Reaction Steps

  • The reaction typically involves a nucleophilic substitution or an electrophilic addition, depending on the nature of the substituent.
  • The patent may specify particular reaction conditions, such as pH, temperature, and reaction time, to optimize the yield and purity of the product.

Purification and Characterization

  • After the reaction, the product is purified using techniques such as crystallization, chromatography, or distillation.
  • The purified compound is then characterized using analytical methods like NMR, IR, or X-ray crystallography to confirm its structure and properties.

Crystal Form of the Compounds

One of the significant aspects of this patent is the description of the crystal form of the N-substituted sulfonamide compounds. This includes:

Crystal Structure

  • The patent details the crystal structure of the compounds, which can be crucial for their stability, solubility, and bioavailability.
  • The crystal structure is often determined using X-ray crystallography.

Polymorphism

  • The patent may also discuss polymorphism, where the compound can exist in multiple crystal forms, each with different properties.

Patent Landscape

The patent landscape for N-substituted sulfonamide compounds is complex and involves various players in the chemical and pharmaceutical industries.

Prior Art

  • The patent must distinguish itself from prior art, which includes existing methods and compounds in the field.
  • The novelty and non-obviousness of the invention are critical for patentability[2].

Related Patents

  • There are likely other patents related to sulfonamide compounds, each with their own specific claims and methods.
  • These patents collectively form a mosaic of intellectual property in the field, influencing how new inventions are developed and protected.

Economic and Strategic Value

The value of a patent like US10774072B2 can be significant, both economically and strategically.

Valuation Methods

  • The value of a patent can be determined using cost, income, and market approaches. For example, the cost approach considers the development costs, while the income approach looks at future benefits. The market approach compares the patent to similar assets that have been sold[4].

Market Impact

  • Patents like this one can provide a competitive edge in the market by protecting unique methods and compounds.
  • Companies may acquire or license such patents to enhance their product portfolio and protect their intellectual property.

Legal Considerations

The legal status and enforcement of the patent are crucial for its holders.

Patent Infringement

  • The patent holder has the right to sue for infringement if another party uses the patented method or compound without permission.
  • Legal battles, such as those seen in cases involving abstract ideas versus patent-eligible inventions, highlight the importance of clear and enforceable claims[2].

Small Claims Patent Court

  • There is ongoing discussion about the establishment of a small claims patent court to handle smaller-scale patent disputes more efficiently and cost-effectively[5].

Key Takeaways

  • Method of Production: The patent describes a specific method for producing N-substituted sulfonamide compounds, including reaction steps and conditions.
  • Crystal Form: The crystal structure and polymorphism of the compounds are critical aspects of the patent.
  • Patent Landscape: The patent must be distinguished from prior art and fits into a broader landscape of related patents.
  • Economic Value: The patent's value can be determined using various methods and provides a strategic advantage in the market.
  • Legal Considerations: Clear claims and enforcement mechanisms are essential for protecting the patent.

FAQs

  1. What is the main subject of US10774072B2?

    • The main subject is the method of producing N-substituted sulfonamide compounds and the characteristics of these compounds.
  2. How are N-substituted sulfonamide compounds produced according to the patent?

    • The production involves reacting a sulfonamide compound with a suitable substituent under specific conditions.
  3. Why is the crystal form of the compounds important?

    • The crystal form affects the stability, solubility, and bioavailability of the compounds.
  4. How is the value of a patent like US10774072B2 determined?

    • The value can be determined using cost, income, and market approaches.
  5. What is the significance of a small claims patent court in the context of this patent?

    • A small claims patent court could provide a more efficient and cost-effective way to handle smaller-scale patent disputes related to this and similar patents.

Sources

  1. US10774072B2 - Crystal of N-substituted sulfonamide compound - Google Patents
  2. AI VISUALIZE, INC. v. NUANCE COMMUNICATIONS, INC. - CAFC
  3. Patent Claims Research Dataset - USPTO
  4. The value of a patent - Perpetual Motion Patents
  5. U.S. Patent Small Claims Court - ACUS

More… ↓

⤷  Try for Free


Drugs Protected by US Patent 10,774,072

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
Ocuvex Therap OMLONTI omidenepag isopropyl SOLUTION;OPHTHALMIC 215092-001 Sep 22, 2022 DISCN Yes No 10,774,072 ⤷  Try for Free Y ⤷  Try for Free
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.